Aflibercept, commonly known by the brand name Eylea, is a medication used to treat various eye conditions, primarily those related to vision problems and abnormal blood vessel growth in the eye. The primary use of Aflibercept (Eylea) is for the treatment of the following eye conditions:

1. Neovascular Age-Related Macular Degeneration (AMD): Aflibercept is used to treat neovascular or “wet” age-related macular degeneration. This condition involves the abnormal growth of blood vessels in the back of the eye, which can lead to vision loss. Aflibercept helps inhibit this abnormal vessel growth and reduce leakage, preserving or even improving vision in some cases.
2. Macular Edema Following Retinal Vein Occlusion (RVO): Aflibercept is used to treat macular edema that can occur after a blockage or occlusion of retinal veins. This condition can lead to swelling and fluid leakage in the macula, a part of the eye essential for clear central vision.
3. Diabetic Macular Edema (DME): Aflibercept is also used for diabetic macular edema, a complication of diabetes that can lead to swelling in the macula and vision impairment.
4. Diabetic Retinopathy: In some regions, Aflibercept is also approved for the treatment of diabetic retinopathy, a condition in which high blood sugar damages the blood vessels of the retina.

Aflibercept is administered via intravitreal injections into the eye, typically performed by an ophthalmologist. These injections deliver the medication directly to the affected area of the eye. The frequency of injections and the duration of treatment may vary based on the specific eye condition and individual patient response. This treatment has been effective in helping to preserve and, in some cases, improve vision in individuals with these eye conditions. However, like all medications, Aflibercept can have potential side effects and risks, and its use should be closely monitored by a healthcare provider with expertise in ophthalmology.

MEDICAL USE:

Aflibercept is used to treat certain serious eye conditions (such as wet age-related macular degeneration – wet AMD, macular edema following central retinal vein occlusion, diabetic macular edema). This medication can help preserve vision and prevent blindness.